tiprankstipranks
eFFECTOR Therapeutics (EFTR)
OTHER OTC:EFTR
US Market
Holding EFTR?
Track your performance easily

eFFECTOR Therapeutics (EFTR) Financial Statements

263 Followers

eFFECTOR Therapeutics Financial Overview

eFFECTOR Therapeutics's market cap is currently ―. The company's EPS TTM is $-13.315; its P/E ratio is >-0.01; eFFECTOR Therapeutics is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 27.00M--$ 27.00M$ -26.32M
Gross Profit$ 27.00M--$ 27.00M$ -26.32M
EBIT$ -8.09M$ -7.55M$ -7.64M$ -9.32M-
EBITDA$ -8.06M$ -7.53M$ -7.62M$ -9.30M-
Net Income Common Stockholders$ -8.83M$ -8.30M$ -8.36M$ -10.01M$ -9.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 25.38M$ 17.78M$ 25.02M$ 19.01M$ 26.31M
Total Assets$ 27.13M$ 20.16M$ 26.89M$ 21.93M$ 29.08M
Total Debt$ 232.00K$ 77.00K$ 94.00K$ 109.00K$ 120.00K
Net Debt$ -25.15M$ -17.70M$ -24.93M$ -18.90M$ -26.19M
Total Liabilities$ 26.30M$ 24.13M$ 24.31M$ 26.74M$ 25.18M
Stockholders Equity$ 827.00K$ -3.97M$ 2.58M$ -4.81M$ 3.94M
Cash Flow-
Free Cash Flow$ -7.28M$ -7.76M$ -8.62M$ -7.65M-
Operating Cash Flow$ -7.28M$ -7.75M$ -8.59M$ -7.64M$ -6.78M
Investing Cash Flow$ -6.32M$ -1.92M$ -1.57M$ 9.03M$ 3.62M
Financing Cash Flow$ 14.23M$ 342.00K$ 14.57M$ 212.00K$ -37.00K
Currency in USD

eFFECTOR Therapeutics Earnings and Revenue History

eFFECTOR Therapeutics Debt to Assets

eFFECTOR Therapeutics Cash Flow

eFFECTOR Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis